Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 1B1 (CYP1B1) is a heme-containing monooxygenase involved in the metabolism of endogenous and exogenous compounds. It participates in Phase I reactions of drug and xenobiotic metabolism, cholesterol synthesis, steroid hormone metabolism, and is critical for estrogen metabolism. CYP1B1 is predominantly expressed in extrahepatic tissues and plays a role in eye development and cancer risk. Its expression is regulated by the aryl hydrocarbon receptor and it modulates redox balance within cells.
Inhibition of CYP1B1 enzymatic activity (not specified in the document but implied by therapeutic relevance)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 family 1 subfamily B member 1 (CYP1B1).